Tessera Therapeutics
Dhruv Bhandary is a seasoned professional with extensive experience in architectural roles within the biotech and pharmaceutical industries. Currently, Dhruv serves as a Senior Architect at Tessera Therapeutics since February 2022. Prior to this position, Dhruv held similar senior architect roles at Voyager Therapeutics, Inc. from September 2016 to February 2022, Infinity Pharmaceuticals from 2011 to September 2016, IMS Health from 2003 to March 2011, and Millennium Pharmaceuticals from 1997 to 2003. Dhruv began the career as a Senior Systems Analyst at Merck & Co., Inc. from 1991 to 1996. Academic qualifications include a Bachelor of Science in Electrical Engineering from Rutgers University, which was obtained in 1991.
This person is not in any teams
This person is not in any offices
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.